4//SEC Filing
INTROGEN THERAPEUTICS INC 4
Accession 0001426170-08-000004
CIK 0001018710operating
Filed
May 19, 8:00 PM ET
Accepted
May 20, 2:42 PM ET
Size
5.6 KB
Accession
0001426170-08-000004
Insider Transaction Report
Form 4
ALBRECHT JAMES W JR
Chief Executive Officer
Transactions
- Award
Stock Option
2008-05-16+100,000→ 100,000 totalExercise: $2.74Exp: 2018-05-15→ Common stock (100,000 underlying)
Footnotes (2)
- [F1]Right to buy.
- [F2]This option vests in four equal annual installments beginning on the 12-month anniversary of May 16, 2008.
Documents
Issuer
INTROGEN THERAPEUTICS INC
CIK 0001018710
Entity typeoperating
Related Parties
1- filerCIK 0001018710
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 2:42 PM ET
- Size
- 5.6 KB